Skip to main content

Dr. Vivek Bhalla, MD

Nephrology (Kidney) (Nephrology Physician)

300 Pasteur Dr
Stanford, CA 94305

Who else practices at this address →

Santa Clara County includes mental health (13% of residents) shortage areas. About shortage areas

Call (650) 723-4000

  • Medicare participating

At a glance

Years since graduation
28
In the NPI registry since
2006
Medicare patients seen, 2024
166

Licensed in California since 1999, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1998Medical school: University of California, San Diego School of Medicine
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Nephrology Physician primary
    CA license A70125 (first issued 1999; current)
  • Internal Medicine Physician
    CA license A70125 (first issued 1999; current)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Nephrology (Kidney) per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
166
Services billed
362
Patients’ average age
70
Most frequent Medicare services, 2023
ServiceTimesPatients
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes12980
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes11860
Established patient office or other outpatient visit, 20-29 minutes4837
Established patient office or other outpatient visit, 30-39 minutes4233
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes3131
Hemodialysis procedure with physician evaluation3017
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes2718
Established patient office or other outpatient visit, 40-54 minutes2219
Established patient office or other outpatient visit, 10-19 minutes1917
New patient office or other outpatient visit, 60-74 minutes1515

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 3 companies reported 41 payments worth $22,091 in total to this clinician.

By company
Medtronic, Inc.$10,769
Idorsia Pharmaceuticals US Inc$5,766
AstraZeneca Pharmaceuticals LP$5,557
By type
Consulting Fee$17,530
Travel and Lodging$3,452
Food and Beverage$1,109

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Oct 1, 2025Medtronic, Inc.
Oct 1, 2025
Consulting Fee
SYMPLICITY G3 · Renal Denervation System
$7,916
Jun 19, 2025Idorsia Pharmaceuticals US Inc
Jun 19, 2025
Consulting Fee
TRYVIO · Hypertension
$4,865
Apr 21, 2025AstraZeneca Pharmaceuticals LP
Apr 21, 2025
Consulting Fee
Company’s descriptionResearch Related Service
$1,499
Oct 1, 2025AstraZeneca Pharmaceuticals LP
Oct 1, 2025
Consulting Fee$1,200
Dec 6, 2025AstraZeneca Pharmaceuticals LP
Dec 6, 2025
Consulting Fee
Company’s descriptionResearch Related Service
$800
Apr 21, 2025AstraZeneca Pharmaceuticals LP
Apr 21, 2025
Travel and Lodging
travel to Chicago, IL
Company’s descriptionResearch Related Service
$796
Jun 19, 2025Idorsia Pharmaceuticals US Inc
Jun 19, 2025
Travel and Lodging
TRYVIO · Hypertension · travel to Chicago, IL · in-kind
$653
Jul 10, 2025Medtronic, Inc.
Jul 10, 2025
Travel and Lodging
SYMPLICITY G3 · Renal Denervation System · travel to Minneapolis, MN · in-kind
$619
Apr 21, 2025AstraZeneca Pharmaceuticals LP
Apr 21, 2025
Travel and Lodging
travel to Chicago, IL
Company’s descriptionResearch Related Service
$460
May 7, 2025Medtronic, Inc.
May 7, 2025
Consulting Fee
SYMPLICITY G3 · Renal Denervation System
$425
All 22 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 6, 2025AstraZeneca Pharmaceuticals LP
Dec 6, 2025
Consulting Fee
Company’s descriptionResearch Related Service
$800
Dec 4, 2025AstraZeneca Pharmaceuticals LP
Dec 4, 2025
Consulting Fee
Company’s descriptionResearch Related Service
$400
Oct 1, 2025Medtronic, Inc.
Oct 1, 2025
Consulting Fee
SYMPLICITY G3 · Renal Denervation System
$7,916
Oct 1, 2025AstraZeneca Pharmaceuticals LP
Oct 1, 2025
Consulting Fee$1,200
Sep 3, 2025Medtronic, Inc.
Sep 3, 2025
Travel and Lodging
SYMPLICITY G3 · Renal Denervation System · travel to Minneapolis, MN · in-kind
$43.51
Aug 28, 2025Medtronic, Inc.
Aug 28, 2025
Travel and Lodging
SYMPLICITY G3 · Renal Denervation System · travel to Minneapolis, MN · in-kind
$29.80
Aug 27, 2025Medtronic, Inc.
Aug 27, 2025
Travel and Lodging
SYMPLICITY G3 · Renal Denervation System · travel to Minneapolis, MN · in-kind
$139
Aug 26, 2025Medtronic, Inc.
Aug 26, 2025
Travel and Lodging
SYMPLICITY G3 · Renal Denervation System · travel to Minneapolis, MN · in-kind
$179
Aug 26, 2025Medtronic, Inc.
Aug 26, 2025
Travel and Lodging
SYMPLICITY G3 · Renal Denervation System · travel to Minneapolis, MN · in-kind
$28.68
Aug 26, 2025Medtronic, Inc.
Aug 26, 2025
Travel and Lodging
SYMPLICITY G3 · Renal Denervation System · travel to Minneapolis, MN · in-kind
$28.34
Aug 25, 2025Medtronic, Inc.
Aug 25, 2025
Travel and Lodging
SYMPLICITY G3 · Renal Denervation System · travel to Minneapolis, MN · in-kind
$179
Aug 25, 2025Medtronic, Inc.
Aug 25, 2025
Travel and Lodging
SYMPLICITY G3 · Renal Denervation System · travel to Minneapolis, MN · in-kind
$28.68
Jul 10, 2025Medtronic, Inc.
Jul 10, 2025
Travel and Lodging
SYMPLICITY G3 · Renal Denervation System · travel to Minneapolis, MN · in-kind
$619
Jul 10, 2025Medtronic, Inc.
Jul 10, 2025
Travel and Lodging
SYMPLICITY G3 · Renal Denervation System · travel to Minneapolis, MN · in-kind
$4.68
Jun 19, 2025Idorsia Pharmaceuticals US Inc
Jun 19, 2025
Consulting Fee
TRYVIO · Hypertension
$4,865
Jun 19, 2025Idorsia Pharmaceuticals US Inc
Jun 19, 2025
Travel and Lodging
TRYVIO · Hypertension · travel to Chicago, IL · in-kind
$653
May 16, 2025Medtronic, Inc.
May 16, 2025
Consulting Fee
SYMPLICITY G3 · Renal Denervation System
$425
May 7, 2025Medtronic, Inc.
May 7, 2025
Consulting Fee
SYMPLICITY G3 · Renal Denervation System
$425
Apr 21, 2025AstraZeneca Pharmaceuticals LP
Apr 21, 2025
Consulting Fee
Company’s descriptionResearch Related Service
$1,499
Apr 21, 2025AstraZeneca Pharmaceuticals LP
Apr 21, 2025
Travel and Lodging
travel to Chicago, IL
Company’s descriptionResearch Related Service
$796
Apr 21, 2025AstraZeneca Pharmaceuticals LP
Apr 21, 2025
Travel and Lodging
travel to Chicago, IL
Company’s descriptionResearch Related Service
$460
Apr 21, 2025AstraZeneca Pharmaceuticals LP
Apr 21, 2025
Travel and Lodging
travel to Chicago, IL
Company’s descriptionResearch Related Service
$263

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in California →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $48,544 in research payments for these studies, mostly to the institutions running them.

  • A Randomised,Double Blind,Placebo Controlled,Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants with Uncontrolled Hypertension on Two or More Medications including Participants with R…
    AstraZeneca Pharmaceuticals LP

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Nephrology (Kidney) clinicians in Stanford

Sources

NPI registry (CMS NPPES, November 2026; record last updated April 17, 2024), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1730118738. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.